Table 2 Perioperative data of the cohort
Characteristics | Results (n = 7) |
|---|---|
Follow-up time (months), median (range) | 46 (30–77) |
Operative time (min), median (IQRs) | 360 (350–450) |
Estimated blood loss (ml), median (IQRs) | 600 (500–800) |
Patients receiving transfusion (no./percent) | 4 (57.1) |
Postoperative hospital stay (day), median (IQRs) | 21 (21–26) |
Short-term perioperative complication (< 3 months),*n (%) | |
Clavien I non-compressive lymphocele | 2 (28.6) |
Clavien I urine retention by mucous plug | 3 (42.9) |
Clavien IVa asthma attack | 1 (14.3) |
Long-term perioperative complication (> 3 months),*n (% sides) | |
Clavien IIIb ureteroileal anastomosis stenosis (left vs. right) | 2 (14.2)/1 (7.1) |
eGFR (ml/min), median (IQR) (preoperative vs. postoperative) | 76 (70–77)/72 (67–80)# |
Intestinal obstruction | 0 (0) |
Urinary incontinence (no./percent) | 0 (0) |
Urinary retention (no./percent) | 3 (42.9) |
Urethral stenosis | 0 (0) |
Urinary tract infection | 0 (0) |
Metabolism acidosis | 0 (0) |
Neobladder capacity (ml), median (IQRs) | 550 (500–650) |
Residual urine (ml), median (IQRs) | 20 (15–30) |
Neobladder pressure at maximum capacity (cm H2O), median (IQRs) | 20 (10–25) |
Local recurrence | 1 (14.3) |